At MDS Pharma Services, we have extensive experience in genotoxicity studies and offer the core battery of genotoxicity tests in compliance with GLP and international regulatory guidelines. These tests comprise gene mutation and chromosomal aberration assays.
In addition screening variations of the regulatory genotoxicity tests have been developed and validated at our laboratories in Lyon, France.
These genotoxicity assays may be coupled with lead identification or early lead optimization assays, available at MDS Pharma Services pharmacology services, in order to deliver a tailored package of scientific services for optimized compound development.
For more information on study design, pricing, contract and turnaround contact your MDS Pharma Services representative.
